The management of epilepsy in pregnancy

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 116, Issue 6, 2009, Pages 758-767

  Walker, S P ^a,b   Permezel, M ^a,b   Berkovic, S F ^b  

^a MERCY HOSPITAL FOR WOMEN   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Epilepsy; Pregnancy; Reproduction

Indexed keywords

ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CONTRACEPTIVE AGENT; ETHINYLESTRADIOL PLUS LEVONORGESTREL; ETIRACETAM; ETONOGESTREL; FELBAMATE; FOLIC ACID; GABAPENTIN; GESTAGEN; LAMOTRIGINE; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PREGABALIN; PRIMIDONE; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN; VITAMIN K GROUP; ZONISAMIDE;

BIRTH DEFECT; COGNITIVE DEFECT; CONGENITAL MALFORMATION; CONTRACEPTION; DRUG CLEARANCE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG EXPOSURE; DRUG MEGADOSE; DRUG METABOLISM; DRUG MONITORING; DRUG PROTEIN BINDING; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; DRUG WITHDRAWAL; EPILEPSY; FEMALE FERTILITY; FERTILITY; HORMONAL CONTRACEPTION; HUMAN; INTRAPARTUM CARE; MATERNAL CARE; MATERNAL MORBIDITY; MONOTHERAPY; NEONATAL HEMORRHAGE; PERINATAL MORBIDITY; PREGNANCY; PREGNANCY OUTCOME; PREPREGNANCY CARE; PRIORITY JOURNAL; PUERPERIUM; REPRODUCTION; REVIEW; SEIZURE; TERATOGENICITY; TREATMENT OUTCOME;

ABNORMALITIES, DRUG-INDUCED; ANTICONVULSANTS; EPILEPSY; FEMALE; HUMANS; POSTNATAL CARE; PRECONCEPTION CARE; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 65349100501     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2009.02141.x     Document Type: Review

References (87)

1. Kampman MT, Johansen S, Stenvold H, Acharya G. Management of women with epilepsy: are guidelines being followed? Results from case-note reviews and a patient questionnaire. Epilepsia 2005 46 : 1286 92.
2. Luef GJ. Epilepsy and sexuality. Seizure 2008 17 : 127 30.
3. Herzog AG. Disorders of reproduction in patients with epilepsy: primary neurological mechanisms. Seizure 2008 17 : 101 10.
4. Isojarvi J. Disorders of reproduction in patients with epilepsy: antiepileptic drug related mechanisms. Seizure 2008 17 : 111 9.
5. Morrell MJ, Hayes FJ, Sluss PM, Adams JM, Bhatt M, Ozkara C, et al. Hyperandrogenism, ovulatory dysfunction, and polycystic ovary syndrome with valproate versus lamotrigine. Ann Neurol 2008 64 : 200 11.
6. Artama M, Isojarvi JIT, Raitanen J, Auvinen A. Birth rate among patients with epilepsy: a nationwide population-based cohort study in Finland. Am J Epidemiol 2004 159 : 1057 63.
7. Artama M, Isojarvi JIT, Auvinen A. Antiepileptic drug use and birth rate in patients with epilepsy - a population-based cohort study in Finland. Hum Reprod 2006 21 : 2290 5.
8. Sabers A. Pharmacokinetic interactions between contraceptives and antiepileptic drugs. Seizure 2008 17 : 141 4.
9. Dutton C, Foldvary-Schaefer N. Contraception in women with epilepsy: pharmacokinetic interactions, contraceptive options and management. Int Rev Neuorobiol 2008 83 : 113 34.
10. Sidhu J, Job S, Singh S, Philipson R. The pharmacokinetic and pharmacodynamic consequences of the co-administration of lamotrigine and a combined oral contraceptive in healthy female subjects. Br J Clin Pharmacol 2006 61 : 191 9.
11. O'Brien MD, Guillebaud J. Contraception for women with epilepsy. Epilepsia 2006 47 : 1419 22.
12. Schwenkhagen AM, Stodieck SRG. Which contraception for women with epilepsy? Seizure 2008 17 : 145 50.
13. Zupanc ML. antiepileptic drugs and hormonal contraceptives in adolescent women with epilepsy. Neurology 2006 66 : S37 45.
14. Crawford P. Best practice guidelines for the management of women with epilepsy. Epilepsia 2005 46 (Suppl 9 117 24.
15. Sabers A, Buchholt JM, Uldall P, Hansen EL. Lamotrigine plasma levels reduced by oral contraceptives. Epilepsy Res 2001 47 : 151 4.
16. Ohman I, Luef G, Tomson T. Effects of pregnancy and contraception on lamotrigine disposition: new insights through analysis of lamotrigine metabolites. Seizure 2008 17 : 199 202.
17. Christensen J, Petrenaite V, Atterman J, Sidenius P, Ohman I, Tomson T, et al. Oral contraceptives induce lamotrigine metabolism: evidence from a double-blind, placebo-controlled trial. Epilepsia 2007 48 : 484 9.
18. Haukkamaa M. Contraception by Norplant subdermal capsules is not reliable in epileptic patients on anticonvulsant treatment. Contraception 1986 33 : 559 65.
19. Odlind O, Olsson SE. Enhanced metabolism of levonorgestrel during phenytoin treatment in a woman with Norplant implants. Contraception 1986 33 : 257 61.
20. Shane-McWhorter L, Cerveny JD, MacFarlane LL, Osborn C. Enhanced metabolism of levonorgestrel during phenobarbitol treatment and resultant pregnancy. Pharmacotherapy 1998 18 : 1360 4.
21. Schindlbeck C, Janni W, Friese K. Failure of implanon contraception in a patient taking carbamazepine for epilepsia. Arch Gynecol Obstet 2006 273 : 255 6.
22. Harrison-Woolrych M, Hill R. Unintended pregnancies with the etonogestrel implant (Implanon): a case series from postmarketing experience in Australia. Contraception 2005 71 : 306 8.
23. Bensouda-Grimaldi L, Jonville-Bera AP, Beau-Salinas F, Llabres S, Autret-Leca E. Insertion problems, removal problems, and contraception failures with Implanon. Gynecol Obstet Fertil 2005 33 : 986 90.
24. Bounds W, Guillebaud J. Observational series on women using the contraceptive Mirena concurrently with anti-epileptic and other enzyme-inducing drugs. J Fam Plann Reprod Health Care 2002 28 : 78 80.
25. Martinez-Juarez IE, Alonso ME, Medina MT, Duron RM, Bailey JN, Lopez-Ruiz M, et al. Juvenile myoclonic epilepsy subsyndromes: family studies and long-term follow-up. Brain 2006 129 : 1269 80.
26. Tomson T, Hiilesnaa V. Epilepsy in pregnancy. BMJ 2007 335 : 769 73.
27. Artama M, Auvinen A, Raudaskoski T, Isojarvi I, Isojarvi J. Antiepileptic drug use of women with epilepsy and congenital malformations in the offspring. Neurology 2005 64 : 1874 8.
28. LaJoie J, Moshe SL. Effects of seizures and their treatment on fetal brain. Epilepsia 2004 45 (Suppl 8 48 52.
29. Tomson T, Perucca E, Battino D. Navigating toward fetal and maternal health: the challenge of treating epilepsy in pregnancy. Epilepsia 2004 45 : 1171 523.
30. Tomson T, Battino D, Bonizzoni E, Craig J, Lindhout D, Perucca E, et al. EURAP: an international registry of antiepileptic drugs and pregnancy. Epilepsia 2004 45 : 1463 4.
31. Holmes LB, Wyszynski DF. North American Antiepileptic Drug Registry. Epilepsia 2004 45 : 1465.
32. Russell AJC, Craig JJ, Morrison P, et al. UK Epilepsy and Pregnancy Group. Epilepsia 2004 45 : 1467.
33. Vajda FJ, Hitchcock A, Graham J, O'Brien T, Lander C, Eadie M. The Australian Register of Antiepileptic Drugs in Pregnancy: the first 1002 pregnancies. Aust N Z J Obstet Gynaecol 2007 47 (6 468 74.
34. Cunnington MC. The International Lamotrigine Pregnancy Registry Update for the Epilepsy Foundation. Epilepsia 2004 45 : 1468.
35. Wide K, Winbladh B, Kallen B. Major malformations in infants exposed to antiepileptic drugs in utero, with emphasis on carbamazepine and valproic acid: a nation-wide, population-based study. Acta Paediatr 2004 93 : 174 6.
36. Tomson T, Battino D, French J, Harden C, Holmes L, Morrow J, et al. Antiepileptic drug exposure and major congenital malformations: the role of pregnancy registries. Epilepsy Behav 2007 11 : 277 82.
37. Meador KJ, Pennell PB, Harden CL, Gordon JC, Tomson T, Kaplan PW, et al. Pregnancy registries in epilepsy: a consensus statement on health outcomes. Neurology 2008 71 : 1109 17.
38. Holmes LB, Harvey EA, Coull BA, Huntington BA, Khoshbin S, Hayes AM, et al. The teratogenicity of anticonvulsant drugs. N Engl J Med 2001 344 : 1132 8.
39. Holmes LB, Wyszynski DF, Lieberman E. The AED (Antiepileptic drug) Pregnancy Registry: a 6-year experience. Arch Neurol 2004 61 : 673 8.
40. Wyszynski DF, Nambisan M, Surve T, Alsdorf RM, Smith CR, Holmes LB. Increased rate of major malformations in exposed to valproate during pregnancy. Neurology 2005 64 : 961 5.
41. Hernandez-Diaz S, Smith CR, Wyszynski DF, Holmes LB. Risk of major malformations among infants exposed to carbamazepine during pregnancy. Birth Defects Res 2007 79 : 351 80.
42. Holmes LB, Baldwin FJ, Smith CR, Habecker F, Glassman L, Wong SI, et al. Increased frequency of isolated cleft palate in infants exposed to lamotrigine during pregnancy. Neurology 2008 70 : 2152 8.
43. Morrow J, Russell A, Guthrie E, Parsons L, Robertson I, Waddell R, et al. Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 2006 77 : 193 8.
44. Hunt S, Craig J, Russell A, Guthrie E, Parsons L, Robertson I, et al. Levetiracetam in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register. Neurology 2006 67 : 1876 9.
45. Hunt S, Russell A, Smithson WH, Parsons L, Robertson I, Waddell R, et al. Topiramate in pregnancy. Neurology 2008 71 : 272 6.
46. Cunnington M, Ferber S, Quartey G, The International Lamotrigine Pregnancy Registry Scientific Advisory Committee. Effect of dose on the frequency of major birth defects following fetal exposure to lamotrigine monotherapy in an international observational study. Epilepsia 2007 48 : 1207 10.
47. Meador K, Reynolds MW, Crean S, Fahrbach K, Probst C. Pregnancy outcomes in women with epilepsy: a systematic review and meta-analysis of published pregnancy registries and cohorts. Epilepsy Res 2008 81 : 1 13.
48. Canger R, Battino D, Canevini MP, Fumarola C, Guidolin L, Vignoli A, et al. Malformations in offspring of women with epilepsy: a prospective study. Epilepsia 1999 40 : 1231 6.
49. Kaneko S, Battino D, Andermann E, Wada K, Kan R, Takeda A, et al. Congenital malformations due to antiepileptic drugs. Epilepsy Res 1999 33 : 145 58.
50. Vajda FJE, Eadie MJ. Maternal valproate dosage and foetal malformations. Acta Neurol Scand 2005 112 : 137 43.
51. Dolk H, Jentink J, Loane M, Morris J, de Jong-van den berg LTW. Does lamotrigine use in pregnancy increase orofacial cleft risk relative to other malformations? Neurology 2008 71 : 714 22.
52. Meador K, Penovich P. What is the risk of orofacial clefts from lamotrigine exposure during pregnancy? Neurology 2008 71 : 706 7.
53. Ornoy A, Zvi N, Arnon J, Wajnberg R, Shechtman S, Diav-Citrin O. The outcome of pregnancy following topiramate treatment: a study on 52 pregnancies. Reprod Toxicol 2008 25 : 388 9.
54. Ten Berg K, Samren EB, Van Oppen AC, Engelsman M, Lindhout D. Levetiracetam use and pregnancy outcome. Reprod Toxicol 2005 20 : 175 8.
55. Eisenschenk S. Treatment with oxcarbazepine during pregnancy. Neurologist 2006 12 : 249 54.
56. Montouris G. Gabapentin exposure in human pregnancy: results from the gabapentin pregnancy registry. Epilepsy Behav 2003 4 : 310 7.
57. Sorri I, Herrgard E, Viinikainen K, Paakkonen A, Heinonen S, Kalviainen R. Ophthalmologic and neurologic findings in two children exposed to vigabatrin in utero. Epilepsy Res 2005 65 : 117 20.
58. Kampman MT. Folate status in women of child-bearing age with epilepsy. Epilepsy Res 2007 75 : 52 56.
59. Kjaer D, Horvath-Puhó E, Christensen J, Vestergaard M, Czeizel AE, Sørenesen HT, et al. Antiepileptic drug use, folic acid supplementation and congenital abnormalities: a population-based case-control study. BJOG 2008 115 : 98 103.
60. Meador KJ, Baker G, Cohen MJ, Gaily E, Westerveld M. Cognitive/ behavioural teratogenetic effects of antiepileptic drugs. Epilepsy Behav 2007 11 : 292 302.
61. Adab N, Jacoby A, Smith D, Chadwick D. Additional educational needs in children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 2001 70 : 15 21.
62. Viinikainen K, Eriksson K, Mönkkönen A, Aikiä M, Nieminen P, Heinonen S, et al. The effects of valproate exposure in utero on behavior and the need for educational support in school-age children. Epilepsy Behav 2006 9 : 636 40.
63. Kantola-Sorsa E, Gaily E, Isoaho M, Korkman M. Neuropsychological outcomes in children of mothers with epilepsy. J Int Neuropsychol Soc 2007 13 : 642 52.
64. Vinten J, Adab N, Kini U, Gorry J, Gregg J, Baker GA. Neuropsychological effects of exposure to AED medication in utero. Neurology 2005 64 : 949 54.
65. Thomas SV, Ajaykumar B, Sindhu K, Nair MK, George B, Sarma PS. Motor and mental development of infants exposed to antiepileptic drugs in utero. Epilepsy Behav 2008 13 : 229 36.
66. Oyen N, Vollset SE, Eide MG, Bjerkedal T, Skjaerven R. Maternal epilepsy and offpsrings' intelligence: a population-based study from Norway. Epilepsia 2007 48 : 1731 8.
67. The EURAP Study Group. Seizure control and treatment in pregnancy. Neurology 2006 66 : 354 60.
68. Christensen J, Sabers A, Sidenius P. Oxcarbazepine concentrations during pregnancy: a retrospective study in patients with epilepsy. Neurology 2006 67 : 1497 9.
69. Vajda FJ, Hitchcock A, Graham J, O'Brien T, Lander C, Eadie M. Seizure control in antiepileptic drug-treated pregnancy. Epilepsia 2008 49 : 172 6.
70. Richmond J, Krishnamoorthy P, Anderman E, Benjamin A. Epilepsy and pregnancy: an obstetric perspective. Am J Obstet Gynecol 2004 190 : 371 9.
71. Viinikainen K, Heinonen S, Eriksson K, Kalviainen R. Community-based, prospective, controlled study of obstetric and neonatal outcome of 179 pregnancies in women with epilepsy. Epilepsia 2006 47 : 186 92.
72. Pilo C, Wide K, Winblandh B. Pregnancy, delivery and neonatal complications after treatment with AEDs. Acta Obstet Gynecol Scand 2006 85 : 643 6.
73. Katz O, Levy A, Wiznitzer A, Sheiner E. Pregnancy and perinatal outcome in epileptic women: a population based study. J Matern Fetal Neonatal Med 2006 19 : 21 25.
74. Tomson T, Battino D. Pharmacokinetics and therapeutic drug monitoring of newer antiepileptic drugs during pregnancy and the puerperium. Clin Pharmacokinet 2007 46 : 209 19.
75. Brodtkorb E, Reimers A. Seizure control and pharmacokinetics of antiepileptic drugs in pregnant women with epilepsy. Seizure 2008 17 : 160 5.
76. Patsalos PN, Berry D, Bourgeois BFD, Cloyd JC, Glauser TA, Johannessen SI, et al. Antiepileptic drugs-best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies. Epilepsia 2008 49 : 1239 76.
77. Souka AP, von Kaisenberg CS, Hyett JA, et al. Increased nuchal translucency with normal karyotype. Am J Obstet Gynecol 2005 192 : 1005 21.
78. Dashe JS, Twickler DM, Santos-Ramos R, McIntire DD, Ramus RM. Alpha-fetoprotein detection of neural tube defects and the impact of standard ultrasound. Am J Obstet Gynecol 2006 195 : 1623 8.
79. Lennon CA, Gray DL. Sensitivity and specificity of ultrasound for the detection of neural tube and ventral wall defects in a high-risk population. Obstet Gynecol 1999 94 : 562 6.
80. Choulika S, Grabowski E, Holmes LB. Is antenatal vitamin K prophylaxis needed for pregnant women taking anticonvulsants? Am J Obstet Gynecol 2004 190 : 882 3.
81. Kaaja E, Kaaja R, Matila R, Hiilesmaa V. Enzyme-inducing antiepileptic drugs in pregnancy and the risk of bleeding in the neonate. Neurology 2002 58 : 549 53.
82. Yamasmit W, Chaithongwongwatthana S, Tolosa JE. Prenatal vitamin K1 administration in epileptic women to prevent neonatal haemorrhage: is it effective? J Reprod Med 2006 51 : 463 6.
83. The Epilepsies: The Diagnosis and Management of the Epilepsies in Adults and Children in Primary and Secondary Care. Clinical guideline 20. October 2004 [ http://www.nice.org.uk/CG020NICEguideline ]. Accessed December 2008.
84. Robinson JN, Clearly-Goldman J. Management of epilepsy and pregnancy: an obstetrical perspective. Int Rev Neurobiol 2008 83 : 273 82.
85. Pennell PB, Gidal BE, Sabers A, Gordon J, Perucca E, for the international AED pharmacology work group for the health outcomes in pregnancy and epilepsy forum. Pharmacology of antiepileptic drugs during pregnancy and lactation. Epilepsy Behav 2007 11 : 263 9.
86. Ohman I, Vitols S, Tomson T. Pharmacokinetics of Gabapentin during delivery, in the neonatal period, and lactation: does a fetal accumulation occur during pregnancy? Epilepsia 2005 46 : 1621 4.
87. Fox C, Betts T. How much risk does a woman with active epilepsy pose to her newborn child in the puerperium? A pilot study. Seizure 1999 8 : 367 9.